Literature DB >> 28604941

Induction of New Autoimmune Diseases After Alemtuzumab Therapy for Multiple Sclerosis: Learning From Adversity.

Lawrence Steinman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28604941     DOI： 10.1001/jamaneurol.2017.0325

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  2 in total

Review 1.  Autoimmune Thyroid Diseases in Patients Treated with Alemtuzumab for Multiple Sclerosis: An Example of Selective Anti-TSH-Receptor Immune Response.

Authors:  Mario Rotondi; Martina Molteni; Paola Leporati; Valentina Capelli; Michele Marinò; Luca Chiovato
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-28       Impact factor: 5.555

2.  Inflammasome Proteins As Biomarkers of Multiple Sclerosis.

Authors:  Robert W Keane; W Dalton Dietrich; Juan Pablo de Rivero Vaccari
Journal:  Front Neurol       Date:  2018-03-19       Impact factor: 4.003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.